
ADC Therapeutics
VerifiedDevelops proprietary antibody drugs targeting cancer
Launch date
Employees
Ownership
Market cap
$656m
Net debt
-
Firm valuation
$1.7b (Public information from Apr 2021)
Share price
$8.53 ADCT
Lausanne Canton of Vaud (HQ)